The effects of a nonsteroidal anti-inflammatory drug on the degree of titanium implant osseointegration
dc.authorscopusid | 57191632156 | |
dc.authorscopusid | 55653708100 | |
dc.authorscopusid | 55317812800 | |
dc.contributor.author | Toy V.E. | |
dc.contributor.author | Dundar S. | |
dc.contributor.author | Bozoglan A. | |
dc.date.accessioned | 2024-08-04T20:03:38Z | |
dc.date.available | 2024-08-04T20:03:38Z | |
dc.date.issued | 2020 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | Objective: The aim of this study was to histologically examine the effects of a nonsteroidal anti-inflammatory drug, namely diclofenac sodium (DCS), on the extent of the bone–implant contact (BIC) of titanium implants after four weeks of osseointegration period in a rodent model. Material & methods: Fourteen female Sprague-Dawley rats were divided into two groups: the control (n = 7) and experimental (DCS) groups. Fourteen machine-surfaced titanium implants were placed in the right tibial bones of the rats. The DCS (2 mg/kg) was administered by means of oral gavage to the experimental group for 14 days after four weeks of osseointegration. No medication was administered to the control group throughout the six-week study period. At the end of the study, the rodents were sacrificed and block sections were obtained for histologic evaluation. Results: The mean BIC ratios for the control and DCS groups were 64.15 ± 6.31% and 61.10 ± 6.08%, respectively. No statistically significant difference in terms of the BIC ratios was found between the two groups. Conclusion: The results of this study demonstrate that DCS did not impair the BIC of the implants after four weeks of osseointegration. © 2020 Craniofacial Research Foundation | en_US |
dc.identifier.doi | 10.1016/j.jobcr.2020.06.006 | |
dc.identifier.endpage | 336 | en_US |
dc.identifier.issn | 2212-4268 | |
dc.identifier.issue | 4 | en_US |
dc.identifier.scopus | 2-s2.0-85087911576 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | 333 | en_US |
dc.identifier.uri | https://doi.org/10.1016/j.jobcr.2020.06.006 | |
dc.identifier.uri | https://hdl.handle.net/11616/91961 | |
dc.identifier.volume | 10 | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier B.V. | en_US |
dc.relation.ispartof | Journal of Oral Biology and Craniofacial Research | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Bone implant connection | en_US |
dc.subject | Diclofenac sodium | en_US |
dc.subject | Nonsteroidal anti-inflammatory drug | en_US |
dc.subject | Osseointegration | en_US |
dc.title | The effects of a nonsteroidal anti-inflammatory drug on the degree of titanium implant osseointegration | en_US |
dc.type | Article | en_US |